Bill & Melinda Gates Medical Research Institute Initiates Phase 3 Clinical Trial of Tuberculosis Vaccine Candidate
Cambridge, Mass, USA, March 19, 2024 -/African Media Agency (AMA)/- The Bill & Melinda Gates Medical Research Institute (Gates MRI) today announced that a Phase 3